Rising Costs and Mixed Results: The Complex Landscape of Weight Loss Drugs in the US

Millions of Americans using weight-loss drugs like Ozempic are experiencing unexpected results, with about 20% not losing significant weight and some even gaining weight. Experts attribute this to individual biological differences, underlying health conditions, and the complex nature of obesity. Despite the high cost and potential side effects, the Biden administration plans to expand Medicare and Medicaid coverage for these drugs. However, skepticism remains due to the variability in effectiveness and potential for weight regain after discontinuation.